Home › Pain After Surgery › NCT07223580

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Evaluating The Role Of Corticosteroids In Post-Ureteroscopy Recovery For Urinary Calculi

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Patients who are diagnosed with kidney or ureteral stones confirmed on imaging (CT of the abdomen or pelvis) and who elect for definitive treatment via ureteroscopy with placement of ureteral stent.
* Age 18 years or older
* Patients of either gender
* Patients of all ethnic backgrounds
* Cable of giving informed consent
* Capable and willing to fulfill the requirements of the study.

Exclusion Criteria:

* History of chronic pain
* Chronic use of opioids or other pain medication (\>12 weeks)
* Known allergies to corticosteroids.
* Known or suspected pregnancy
* Inability to give informed consent or unable to meet requirements of the study for any reason.
* Bilateral ureteroscopy
* Current Corticosteroid Use
* Diabetic patients who are insulin dependent

About the study

The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications

What is being tested

• Corticosteroid (drug)
• Placebo (other)

Sponsor: Mayo Clinic · Participants: 90 · Started: Jan 23, 2026

Contact the study team

• Rev V. Vilasan Shylaja · Phone: 480-574-1466

Official record on ClinicalTrials.gov — NCT07223580

Locations in the U.S.

Conditions

• Pain After Surgery

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.